[
    "{\"step_by_step_thinking\": \"Based on the provided documents, trichomegaly is a known side effect of epidermal growth factor receptor inhibitors, including panitumumab. Document [1] mentions that panitumumab can cause acquired pili canaliculi, which is a form of trichomegaly. Document [2] also states that elongation of the eyelashes induced by EGFR inhibitors, including panitumumab, has been observed. Additionally, document [4] reports a case of hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment, which is another EGFR inhibitor. Therefore, based on the available information, the answer is A. yes, panitumumab can cause trichomegaly.\", \"answer_choice\": \"A\"}"
]